CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 100 of 764 entries

View as:

Intravitreal Macugen for Ischaemic Diabetic Macular Oedema

Phase: N/A Priority: Normal

NCT ID: NCT01175070 Org: User:

Start: 01/31/11 End: 03/31/13 Due: 03/31/14

Efficacy of Pain Intervention With Deep Brain Stimulation Neuromodulation

Phase: N/A Priority: Normal

NCT ID: NCT06387914 Org: User:

Start: 08/07/24 End: 05/02/27 Due: 05/02/28

Binocular Vision in Monocular Pseudophakia

Phase: N/A Priority: Normal

NCT ID: NCT01872000 Org: User:

Start: 04/30/13 End: 10/31/18 Due: 10/31/19

13 Valent Pneumococcal Conjugate Vaccine - Follow-on Study

Phase: N/A Priority: Normal

NCT ID: NCT01095471 Org: User:

Start: 04/30/10 End: 03/31/11 Due: 03/31/12

Treatment of HDL to Reduce the Incidence of Vascular Events HPS2-THRIVE

Phase: N/A Priority: Normal

NCT ID: NCT00461630 Org: User:

Start: 01/31/07 End: 10/31/12 Due: 10/31/13

Clinical Antenatal Randomised Study to CharactErise Key Roles of TetrahydroFOLate in HyperTensive Pregnancies

Phase: N/A Priority: Normal

NCT ID: NCT05434195 Org: User:

Start: 06/01/21 End: 06/30/24 Due: 06/30/25

Glutathione Levels and Compulsivity

Phase: N/A Priority: Normal

NCT ID: NCT02794389 Org: User:

Start: 03/31/16 End: 04/30/17 Due: 04/30/18

Bacterial Transmission Dynamics Study

Phase: N/A Priority: Normal

NCT ID: NCT02401204 Org: User:

Start: 02/28/15 End: 05/31/19 Due: 05/31/20

The Detection of Small Early Liver Cancer With Natural History Follow up

Phase: N/A Priority: Normal

NCT ID: NCT05534906 Org: User:

Start: 05/23/22 End: 06/30/35 Due: 06/30/36

Investigating the Use of Fluorescent Lectins to Identify Dysplasia and Cancer During Endoscopy and Surgery

Phase: N/A Priority: Normal

NCT ID: NCT03070613 Org: User:

Start: 04/23/17 End: 03/01/18 Due: 03/01/19

Artesunate+Sulfadoxine-Pyrimethamine for the Treatment of Uncomplicated Falciparum Malaria

Phase: N/A Priority: Normal

NCT ID: NCT01115439 Org: User:

Start: 03/31/10 End: 07/31/11 Due: 07/31/12

Oxygen Nanobubble Drink Impact on Exercise in Elite Athletes

Phase: N/A Priority: Normal

NCT ID: NCT05777642 Org: User:

Start: 04/20/23 End: 06/18/24 Due: 06/18/25

A Functional Magnetic Resonance Imaging Investigation of Transcranial Direct Current Stimulation

Phase: N/A Priority: Normal

NCT ID: NCT03623815 Org: User:

Start: 02/05/15 End: 10/06/15 Due: 10/06/16

Cotrimoxazole Prophylaxis in Severely Malnourished Children

Phase: N/A Priority: Normal

NCT ID: NCT00934492 Org: User:

Start: 11/30/09 End: 04/30/14 Due: 04/30/15

LITMUS Imaging Study

Phase: N/A Priority: Normal

NCT ID: NCT05479721 Org: User:

Start: 09/04/19 End: 10/31/25 Due: 10/31/26

Compare the Effectiveness Between Existing Treatment and New Treatment

Phase: N/A Priority: Normal

NCT ID: NCT01640587 Org: User:

Start: 11/30/13 End: 03/30/17 Due: 03/30/18

Clinical and Developmental Outcomes of Babies Who Became Yellow in the First Month of Life

Phase: N/A Priority: Normal

NCT ID: NCT02927093 Org: User:

Start: 10/31/16 End: 03/31/17 Due: 03/31/18

VAC071: A Study to Assess Efficacy of the ChAd63/MVA PvDBP Vaccines

Phase: N/A Priority: Normal

NCT ID: NCT04009096 Org: User:

Start: 07/18/19 End: 07/07/22 Due: 07/07/23

Pharmacokinetic Study of Primaquine and Chloroquine in Healthy Subjects

Phase: N/A Priority: Normal

NCT ID: NCT01218932 Org: User:

Start: 10/31/10 End: 03/31/12 Due: 03/31/13

A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers Who Have Previously Received BCG

Phase: N/A Priority: Normal

NCT ID: NCT00427830 Org: User:

Start: 05/31/03 End: 01/31/05 Due: 01/31/06

Tafenoquine and Primaquine in Colostrum and Breast Milk

Phase: N/A Priority: Normal

NCT ID: NCT04984759 Org: User:

Start: 07/01/23 End: 06/30/25 Due: 06/30/26

Study of Artemether-lumefantrine, Amodiaquine and Primaquine in Healthy Subjects

Phase: N/A Priority: Normal

NCT ID: NCT02696954 Org: User:

Start: 11/18/16 End: 03/31/19 Due: 03/31/20

Digital Alerts for Sepsis: a Qualitative Study

Phase: N/A Priority: Normal

NCT ID: NCT05741801 Org: User:

Start: 11/04/22 End: 07/17/23 Due: 07/17/24

Fluorescent Imaging & Methylene Blue: Ureter Study

Phase: N/A Priority: Normal

NCT ID: NCT03177070 Org: User:

Start: 05/09/16 End: 05/02/17 Due: 05/02/18

Newborn Screening for Spinal Muscular Atrophy

Phase: N/A Priority: Normal

NCT ID: NCT05481164 Org: User:

Start: 03/08/22 End: 03/07/25 Due: 03/07/26

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Intravitreal Macugen for Ischaemic Diabetic Macular Oedema	NCT01175070	University of Oxford	user2@example.com	None	2011-01-31	2013-03-31	2014-03-31	-	-	2025-07-14
Efficacy of Pain Intervention With Deep Brain Stimulation Neuromodulation	NCT06387914	University of Oxford	user2@example.com	None	2024-08-07	2027-05-02	2028-05-02	-	-	2025-07-14
Binocular Vision in Monocular Pseudophakia	NCT01872000	University of Oxford	user2@example.com	None	2013-04-30	2018-10-31	2019-10-31	-	-	2025-07-14
13 Valent Pneumococcal Conjugate Vaccine - Follow-on Study	NCT01095471	University of Oxford	user2@example.com	None	2010-04-30	2011-03-31	2012-03-31	-	-	2025-07-14
Treatment of HDL to Reduce the Incidence of Vascular Events HPS2-THRIVE	NCT00461630	University of Oxford	user2@example.com	None	2007-01-31	2012-10-31	2013-10-31	-	-	2025-07-14
Clinical Antenatal Randomised Study to CharactErise Key Roles of TetrahydroFOLate in HyperTensive Pregnancies	NCT05434195	University of Oxford	user2@example.com	None	2021-06-01	2024-06-30	2025-06-30	-	-	2025-07-14
Glutathione Levels and Compulsivity	NCT02794389	University of Oxford	user2@example.com	None	2016-03-31	2017-04-30	2018-04-30	-	-	2025-07-14
Bacterial Transmission Dynamics Study	NCT02401204	University of Oxford	user2@example.com	None	2015-02-28	2019-05-31	2020-05-31	-	-	2025-07-14
The Detection of Small Early Liver Cancer With Natural History Follow up	NCT05534906	University of Oxford	user2@example.com	None	2022-05-23	2035-06-30	2036-06-30	-	-	2025-07-14
Investigating the Use of Fluorescent Lectins to Identify Dysplasia and Cancer During Endoscopy and Surgery	NCT03070613	University of Oxford	user2@example.com	None	2017-04-23	2018-03-01	2019-03-01	-	-	2025-07-14
Artesunate+Sulfadoxine-Pyrimethamine for the Treatment of Uncomplicated Falciparum Malaria	NCT01115439	University of Oxford	user2@example.com	None	2010-03-31	2011-07-31	2012-07-31	-	-	2025-07-14
Oxygen Nanobubble Drink Impact on Exercise in Elite Athletes	NCT05777642	University of Oxford	user2@example.com	None	2023-04-20	2024-06-18	2025-06-18	-	-	2025-07-14
A Functional Magnetic Resonance Imaging Investigation of Transcranial Direct Current Stimulation	NCT03623815	University of Oxford	user2@example.com	None	2015-02-05	2015-10-06	2016-10-06	-	-	2025-07-14
Cotrimoxazole Prophylaxis in Severely Malnourished Children	NCT00934492	University of Oxford	user2@example.com	None	2009-11-30	2014-04-30	2015-04-30	-	-	2025-07-14
LITMUS Imaging Study	NCT05479721	University of Oxford	user2@example.com	None	2019-09-04	2025-10-31	2026-10-31	-	-	2025-07-14
Compare the Effectiveness Between Existing Treatment and New Treatment	NCT01640587	University of Oxford	user2@example.com	None	2013-11-30	2017-03-30	2018-03-30	-	-	2025-07-14
Clinical and Developmental Outcomes of Babies Who Became Yellow in the First Month of Life	NCT02927093	University of Oxford	user2@example.com	None	2016-10-31	2017-03-31	2018-03-31	-	-	2025-07-14
VAC071: A Study to Assess Efficacy of the ChAd63/MVA PvDBP Vaccines	NCT04009096	University of Oxford	user2@example.com	None	2019-07-18	2022-07-07	2023-07-07	-	-	2025-07-14
Pharmacokinetic Study of Primaquine and Chloroquine in Healthy Subjects	NCT01218932	University of Oxford	user2@example.com	None	2010-10-31	2012-03-31	2013-03-31	-	-	2025-07-14
A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers Who Have Previously Received BCG	NCT00427830	University of Oxford	user2@example.com	None	2003-05-31	2005-01-31	2006-01-31	-	-	2025-07-14
Tafenoquine and Primaquine in Colostrum and Breast Milk	NCT04984759	University of Oxford	user2@example.com	None	2023-07-01	2025-06-30	2026-06-30	-	-	2025-07-14
Study of Artemether-lumefantrine, Amodiaquine and Primaquine in Healthy Subjects	NCT02696954	University of Oxford	user2@example.com	None	2016-11-18	2019-03-31	2020-03-31	-	-	2025-07-14
Digital Alerts for Sepsis: a Qualitative Study	NCT05741801	University of Oxford	user2@example.com	None	2022-11-04	2023-07-17	2024-07-17	-	-	2025-07-14
Fluorescent Imaging & Methylene Blue: Ureter Study	NCT03177070	University of Oxford	user2@example.com	None	2016-05-09	2017-05-02	2018-05-02	-	-	2025-07-14
Newborn Screening for Spinal Muscular Atrophy	NCT05481164	University of Oxford	user2@example.com	None	2022-03-08	2025-03-07	2026-03-07	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance